• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

    1/24/24 7:18:30 AM ET
    $APLS
    $DAVA
    $DXC
    $NFLX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology
    Get the next $APLS alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

    • Keybanc raised Texas Instruments Incorporated (NASDAQ:TXN) price target from $180 to $200. Keybanc analyst John Vinh maintained an Overweight rating. Texas Instruments shares fell 0.3% to close at $174.34 on Tuesday. See how other analysts view this stock.
    • Raymond James increased the price target for Webster Financial Corporation (NYSE:WBS) from $57 to $60. Raymond James analyst Daniel Tamayo maintained an Outperform rating. Webster Financial shares fell 2.3% to close at $49.96 on Tuesday. See how other analysts view this stock.
    • Stifel boosted the price target for NuStar Energy L.P. (NYSE:NS) from $20 to $23. Stifel analyst Selman Akyol downgraded the stock from Buy to Hold. NuStar Energy shares fell 1.3% to close at $21.04 on Tuesday. See how other analysts view this stock.
    • Needham raised Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) price target from $70 to $75. Needham analyst Joseph Stringer maintained a Buy rating. Apellis Pharmaceuticals shares rose 1.1% to close at $66.18 on Tuesday. See how other analysts view this stock.
    • Citigroup boosted the price target for Sunoco LP (NYSE:SUN) from $54 to $65. Citigroup analyst Spiro Dounis upgraded the stock from Neutral to Buy. Sunoco shares fell 1.5% to close at $55.88 on Tuesday. See how other analysts view this stock.
    • BMO Capital cut the price target for Plug Power Inc. (NASDAQ:PLUG) from $3.5 to $2.5. BMO Capital analyst Ameet Thakkar downgraded the stock from Market Perform to Underperform. Plug Power shares gained 31% to close at $3.72 on Tuesday. See how other analysts view this stock.
    • Canaccord Genuity raised Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) price target from $332 to $379. Canaccord Genuity analyst Whitney Ijem downgraded the stock from Hold to Sell. Vertex Pharmaceuticals shares fell 0.1% to close at $439.70 on Tuesday. See how other analysts view this stock.
    • JP Morgan cut DXC Technology Company (NYSE:DXC) price target from $27 to $24. JP Morgan analyst Tien-Tsin Huang downgraded the stock from Neutral to Underweight. DXC Technology shares fell 0.8% to close at $23.10 on Tuesday. See how other analysts view this stock.
    • Morgan Stanley increased Endava plc (NYSE:DAVA) price target from $68 to $80. Morgan Stanley analyst James Faucette downgraded the stock from Overweight to Equal-Weight. Endava shares fell 2.2% to close at $78.28 on Tuesday. See how other analysts view this stock.
    • Keybanc boosted Netflix, Inc. (NASDAQ:NFLX) price target from $545 to $580. Keybanc analyst Justin Patterson maintained an Overweight rating. Netflix shares rose 1.3% to close at $492.19 on Tuesday. See how other analysts view this stock.

     

    Check This Out: Texas Instruments Reports Q4 Results, Joins BlackBerry And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

    Get the next $APLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLS
    $DAVA
    $DXC
    $NFLX

    CompanyDatePrice TargetRatingAnalyst
    Texas Instruments Incorporated
    $TXN
    4/23/2026$320.00Neutral → Buy
    BofA Securities
    Texas Instruments Incorporated
    $TXN
    4/23/2026$250.00Underweight → Equal Weight
    Barclays
    Netflix Inc.
    $NFLX
    4/20/2026$115.00 → $110.00Outperform
    Bernstein
    Texas Instruments Incorporated
    $TXN
    4/17/2026$215.00Underperform → Neutral
    Mizuho
    Texas Instruments Incorporated
    $TXN
    4/9/2026$250.00Hold → Buy
    Stifel
    Webster Financial Corporation
    $WBS
    4/7/2026$69.00Neutral
    UBS
    Netflix Inc.
    $NFLX
    4/6/2026$120.00Neutral → Buy
    Goldman
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    More analyst ratings

    $APLS
    $DAVA
    $DXC
    $NFLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Energy Transfer LP Announces Cash Distribution on Series I Preferred Units

    Energy Transfer LP ("ET") today announced the quarterly cash distribution of $0.2111 per Series I Preferred Unit (NYSE:ETPRI). The cash distribution for the Series I unitholders will be paid on May 15, 2026 to Series I unitholders of record as of the close of business on May 4, 2026. Energy Transfer LP (NYSE:ET) owns and operates one of the largest and most diversified portfolios of energy assets in the United States, with approximately 140,000 miles of pipeline and associated energy infrastructure. Energy Transfer's strategic network spans 44 states with assets in all of the major U.S. production basins. Energy Transfer is a publicly traded limited partnership with core operations that

    4/22/26 4:15:00 PM ET
    $ET
    $SUN
    $SUNC
    Natural Gas Distribution
    Public Utilities
    Integrated oil Companies
    Energy

    TI reports first quarter 2026 financial results and shareholder returns

    Conference call at 3:30 p.m. Central time today on ti.com/irDALLAS, April 22, 2026 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ:TXN) today reported first quarter revenue of $4.83 billion, net income of $1.55 billion and earnings per share of $1.68. Earnings per share included a 5-cent benefit that was not in the company's original guidance.Regarding the company's performance and returns to shareholders, Haviv Ilan, TI's chairman, president and CEO, made the following comments:"Revenue increased 9% sequentially and 19% from the same quarter a year ago with growth led by industrial and data center."Our cash flow from operations of $7.8 billion for the trailing 12 months again un

    4/22/26 4:01:00 PM ET
    $TXN
    Semiconductors
    Technology

    Suncor Energy to release first quarter 2026 financial results

    Calgary, Alberta--(Newsfile Corp. - April 21, 2026) - Suncor Energy (TSX:SU) (NYSE:SU) will release its first quarter financial results on May 5, 2026 before 5:00 p.m. MT (7:00 p.m. ET).A webcast to review the first quarter will be held on May 6, 2026 at 7:30 a.m. MT (9:30 a.m. ET). A question and answer period with analysts will follow brief remarks from management.To listen to the webcast, please follow the instructions provided at https://www.suncor.com/en ca/investors/events-and-presentations. The event will be archived for 90 days.Suncor Energy - Canada's leading integrated energy companySuncor's operations span the full energy value chain, including oil sands mining and in situ operati

    4/21/26 5:00:00 PM ET
    $SU
    $SUN
    Integrated oil Companies
    Energy

    $APLS
    $DAVA
    $DXC
    $NFLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fernandez Raul J bought $250,706 worth of shares (16,446 units at $15.24), increasing direct ownership by 2% to 816,001 units (SEC Form 4)

    4 - DXC Technology Co (0001688568) (Issuer)

    2/3/26 5:55:04 PM ET
    $DXC
    EDP Services
    Technology

    Officer Crespo Jose Luis bought $87,282 worth of shares (37,300 units at $2.34), increasing direct ownership by 14% to 307,332 units (SEC Form 4)

    4 - PLUG POWER INC (0001093691) (Issuer)

    12/17/25 9:06:21 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    CEO & President Kewalramani Reshma bought $3,895,768 worth of shares (10,000 units at $389.58), increasing direct ownership by 9% to 115,968 units (SEC Form 4)

    4 - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Issuer)

    8/7/25 4:23:31 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $DAVA
    $DXC
    $NFLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sullivan Timothy Eugene

    4 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

    4/20/26 4:02:06 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Upadhyay Suketu

    4 - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Issuer)

    4/17/26 4:20:37 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Sachs Bruce I

    4 - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Issuer)

    4/17/26 4:17:34 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $DAVA
    $DXC
    $NFLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 30, 2025 - FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

    For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.  Journavx is the first dr

    1/30/25 5:46:14 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for TRIKAFTA (COPACKAGED) issued to VERTEX PHARMS INC

    Submission status for VERTEX PHARMS INC's drug TRIKAFTA (COPACKAGED) (SUPPL-11) with active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR has changed to 'Approval' on 08/03/2023. Application Category: NDA, Application Number: 212273, Application Classification: Labeling

    8/4/23 4:36:00 AM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $DAVA
    $DXC
    $NFLX
    SEC Filings

    View All

    SEC Form DEFM14A filed by Webster Financial Corporation

    DEFM14A - WEBSTER FINANCIAL CORP (0000801337) (Filer)

    4/23/26 4:46:28 PM ET
    $WBS
    Major Banks
    Finance

    Netflix Inc. filed SEC Form 8-K: Other Events

    8-K - NETFLIX INC (0001065280) (Filer)

    4/22/26 7:13:24 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Texas Instruments Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TEXAS INSTRUMENTS INC (0000097476) (Filer)

    4/22/26 4:03:59 PM ET
    $TXN
    Semiconductors
    Technology

    $APLS
    $DAVA
    $DXC
    $NFLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Texas Instruments upgraded by Barclays with a new price target

    Barclays upgraded Texas Instruments from Underweight to Equal Weight and set a new price target of $250.00

    4/23/26 7:46:31 AM ET
    $TXN
    Semiconductors
    Technology

    Texas Instruments upgraded by BofA Securities with a new price target

    BofA Securities upgraded Texas Instruments from Neutral to Buy and set a new price target of $320.00

    4/23/26 7:46:31 AM ET
    $TXN
    Semiconductors
    Technology

    Bernstein reiterated coverage on Netflix with a new price target

    Bernstein reiterated coverage of Netflix with a rating of Outperform and set a new price target of $110.00 from $115.00 previously

    4/20/26 9:37:22 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $APLS
    $DAVA
    $DXC
    $NFLX
    Leadership Updates

    Live Leadership Updates

    View All

    Plug Power Welcomes Jose Luis Crespo as Chief Executive Officer

    SLINGERLANDS, N.Y., March 03, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions, welcomes Jose Luis Crespo as Chief Executive Officer, marking the start of the Company's next phase of disciplined growth and focused execution. Crespo assumed the role on March 2, 2026. Crespo brings more than 12 years of leadership experience at Plug, most recently serving as President and Chief Revenue Officer, where he drove growth through cost discipline, margin expansion, and capital efficiency. He led Plug's commercial organization during a period of significant scale, helping grow revenue from approximately $27 million in 2013 to more than $700

    3/3/26 7:00:00 AM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

    WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company's board of directors as of March 1. Most recently, Dr. Dolsten served for more than 16 years as chief scientific officer and president, worldwide research, development and medical, at Pfizer, during which he presided over the regulatory approval of more than 36 medicines and vaccines.  "We are thrilled to welcome Mikael to the Apellis Board of Directors," said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. "Mikael is a proven industry leader with deep experience developing innovative medicine

    3/2/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nexus Global Payments Appoints Technical Operator

    PayNet and NETS joint venture awarded contract to be Nexus Technical Operator, with support from Endava and AWS Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement process involving global bidders and marks a major milestone in building an interoperable global payments infrastructure. The evaluation of bidders considered technical capability, operational resilience, cost efficiency, and alignment with Nexus' vision for global interoperability. PayNet and NETS joint venture emerged as the preferred partner due to the proven

    2/9/26 6:21:00 AM ET
    $DAVA
    EDP Services
    Technology

    $APLS
    $DAVA
    $DXC
    $NFLX
    Financials

    Live finance-specific insights

    View All

    TI reports first quarter 2026 financial results and shareholder returns

    Conference call at 3:30 p.m. Central time today on ti.com/irDALLAS, April 22, 2026 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ:TXN) today reported first quarter revenue of $4.83 billion, net income of $1.55 billion and earnings per share of $1.68. Earnings per share included a 5-cent benefit that was not in the company's original guidance.Regarding the company's performance and returns to shareholders, Haviv Ilan, TI's chairman, president and CEO, made the following comments:"Revenue increased 9% sequentially and 19% from the same quarter a year ago with growth led by industrial and data center."Our cash flow from operations of $7.8 billion for the trailing 12 months again un

    4/22/26 4:01:00 PM ET
    $TXN
    Semiconductors
    Technology

    Suncor Energy to release first quarter 2026 financial results

    Calgary, Alberta--(Newsfile Corp. - April 21, 2026) - Suncor Energy (TSX:SU) (NYSE:SU) will release its first quarter financial results on May 5, 2026 before 5:00 p.m. MT (7:00 p.m. ET).A webcast to review the first quarter will be held on May 6, 2026 at 7:30 a.m. MT (9:30 a.m. ET). A question and answer period with analysts will follow brief remarks from management.To listen to the webcast, please follow the instructions provided at https://www.suncor.com/en ca/investors/events-and-presentations. The event will be archived for 90 days.Suncor Energy - Canada's leading integrated energy companySuncor's operations span the full energy value chain, including oil sands mining and in situ operati

    4/21/26 5:00:00 PM ET
    $SU
    $SUN
    Integrated oil Companies
    Energy

    Sunoco LP and SunocoCorp LLC Announce a 6.25% Increase in Quarterly Distributions

    Sunoco LP (NYSE:SUN) ("SUN" or the "Partnership") and SunocoCorp LLC (NYSE:SUNC) ("SUNC") announced a quarterly distribution of $0.9899 per common unit, or $3.9596 on an annualized basis, for the quarter ended March 31, 2026. This represents an increase of approximately 6.25%, or $0.0582 per common unit, as compared to the quarter ended December 31, 2025. This 6.25% increase is inclusive of a one-time step-up of 5% and a quarterly increase of 1.25%. The increase reflects SUN's continued financial stability, execution of highly accretive acquisitions and growth projects, and confidence in future distribution increases. The first quarter of 2026 annualized distribution represents an incre

    4/21/26 8:00:00 AM ET
    $ET
    $SUN
    $SUNC
    Natural Gas Distribution
    Public Utilities
    Integrated oil Companies
    Energy

    $APLS
    $DAVA
    $DXC
    $NFLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by DXC Technology Company

    SC 13G/A - DXC Technology Co (0001688568) (Subject)

    11/14/24 4:15:54 PM ET
    $DXC
    EDP Services
    Technology